You are here

Article Text

Article menu
Download PDFPDF
Rheumatology
From joint pains to hair gains: baricitinib’s double duty for rheumatoid arthritis and alopecia areata
  1. Emer Gates1,2,
  2. Anita Takwale3 and
  3. Muhammad Safwan Jamal4
  1. 1Rheumatology, Royal United Hospitals Bath NHS Foundation Trust, Bath, UK
  2. 2Medicine, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK
  3. 3Dermatology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK
  4. 4Rheumatology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK
  1. Correspondence to Dr Emer Gates; emer.gates1{at}nhs.net

Abstract

Personalised medicine is a key goal across medical specialties today: using biomarkers and knowledge of pathophysiology to ensure the right patients get the right treatment. This becomes more challenging when patients have more than one disease requiring a targeted treatment. Autoimmune diseases commonly co-occur, and thus, multidisciplinary working is important in rheumatology. We present a case where a patient with a new diagnosis of alopecia areata on a background of rheumatoid arthritis was successfully treated with baricitinib monotherapy, with improvement in both conditions.

  • Drugs: musculoskeletal and joint diseases
  • Rheumatoid arthritis
  • Dermatology

https://doi.org/10.1136/bcr-2024-260021

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors The following author was responsible for drafting of the text, sourcing and editing of clinical images, investigation results, drawing original diagrams and algorithms and critical revision for important intellectual content: EG. The following authors gave final approval of the manuscript: EG, AT and MSJ.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.